Literature DB >> 11602760

Folding of hepatitis C virus E1 glycoprotein in a cell-free system.

M Merola1, M Brazzoli, F Cocchiarella, J M Heile, A Helenius, A J Weiner, M Houghton, S Abrignani.   

Abstract

The hepatitis C virus (HCV) envelope proteins, E1 and E2, form noncovalent heterodimers and are leading candidate antigens for a vaccine against HCV. Studies in mammalian cell expression systems have focused primarily on E2 and its folding, whereas knowledge of E1 folding remains fragmentary. We used a cell-free in vitro translation system to study E1 folding and asked whether the flanking proteins, Core and E2, influence this process. We translated the polyprotein precursor, in which the Core is N-terminal to E1, and E2 is C-terminal, and found that when the core protein was present, oxidation of E1 was a slow, E2-independent process. The half-time for E1 oxidation was about 5 h in the presence or absence of E2. In contrast with previous reports, analysis of three constructs of different lengths revealed that the E2 glycoprotein undergoes slow oxidation as well. Unfolded or partially folded E1 bound to the endoplasmic reticulum chaperones calnexin and (with lower efficiency) calreticulin, whereas no binding to BiP/GRP78 or GRP94 could be detected. Release from calnexin and calreticulin was used to assess formation of mature E1. When E1 was expressed in the absence of Core and E2, its oxidation was impaired. We conclude that E1 folding is a process that is affected not only by E2, as previously shown, but also by the Core. The folding of viral proteins can thus depend on complex interactions between neighboring proteins within the polyprotein precursor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602760      PMCID: PMC114700          DOI: 10.1128/JVI.75.22.11205-11217.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers.

Authors:  S Depraetere; E Van Kerschaever; H Van Vlierberghe; A Elewaut; J T Brouwer; H G Niesters; S W Schalm; G Maertens; G Leroux-Roels
Journal:  J Med Virol       Date:  2000-02       Impact factor: 2.327

2.  Conformational changes associated with proteolytic processing of presecretory proteins allow glutathione-catalyzed formation of native disulfide bonds.

Authors:  G Scheele; R Jacoby
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

3.  Interaction between hepatitis C virus core protein and E1 envelope protein.

Authors:  S Y Lo; M J Selby; J H Ou
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 4.  Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.

Authors:  A J Parodi
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

5.  Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes.

Authors:  D N Hebert; B Foellmer; A Helenius
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

6.  Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein.

Authors:  J Dubuisson; S Duvet; J C Meunier; A Op De Beeck; R Cacan; C Wychowski; L Cocquerel
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

7.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 8.  Folding and assembly of viral membrane proteins.

Authors:  R W Doms; R A Lamb; J K Rose; A Helenius
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.

Authors:  J Dubuisson; C M Rice
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.

Authors:  D Moradpour; P Kary; C M Rice; H E Blum
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  18 in total

1.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.

Authors:  Priyanka Shukla; Kristina N Faulk; Suzanne U Emerson
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.

Authors:  Anne Goffard; Nathalie Callens; Birke Bartosch; Czeslaw Wychowski; François-Loïc Cosset; Claire Montpellier; Jean Dubuisson
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

5.  The intraviral protein interaction network of hepatitis C virus.

Authors:  Nicole Hagen; Karen Bayer; Kathrin Rösch; Michael Schindler
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

6.  The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule.

Authors:  Thomas Krey; Jacques d'Alayer; Carlos M Kikuti; Aure Saulnier; Laurence Damier-Piolle; Isabelle Petitpas; Daniel X Johansson; Rajiv G Tawar; Bruno Baron; Bruno Robert; Patrick England; Mats A A Persson; Annette Martin; Félix A Rey
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

7.  Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies.

Authors:  B F F Chumpitazi; L Bouillet; M-T Drouet; L Kuhn; J Garin; J-P Zarski; C Drouet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-12       Impact factor: 3.267

8.  Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

Authors:  Ahmed Wahid; François Helle; Véronique Descamps; Gilles Duverlie; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

9.  Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment.

Authors:  Eike Steinmann; Juliane Doerrbecker; Martina Friesland; Nina Riebesehl; Corinne Ginkel; Julia Hillung; Juliane Gentzsch; Chris Lauber; Richard Brown; Anne Frentzen; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

10.  Japanese encephalitis virus co-opts the ER-stress response protein GRP78 for viral infectivity.

Authors:  Yi-Ping Wu; Chung-Ming Chang; Chun-Yu Hung; Meng-Chieh Tsai; Scott C Schuyler; Robert Yung-Liang Wang
Journal:  Virol J       Date:  2011-03-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.